SCHEMBL1016838

SCHEMBL1016838

COC(=O)c1cc(Cl)ccc1NC(=O)C(=O)NCc1cccc(-c2ccoc2)c1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 5/20 0.81
CNR1 P21554 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
THRB P10828 1/20 0.42
ALDH1A1 P00352 4/20 0.41
HPGD P15428 3/20 0.41
NPC1 O15118 1/20 0.41
NR4A2 P43354 1/20 0.39
TSHR P16473 2/20 0.38
HSD17B10 Q99714 2/20 0.38
KDM4E B2RXH2 2/20 0.38
GAA P10253 1/20 0.38
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015517 0.89 SERPINE1 (1.00) SERPINE1CNR1SMN1; SMN2THRBTSHR
SCHEMBL1015802 0.87 SERPINE1 (0.84) SERPINE1CNR1SMN1; SMN2ALDH1A1HPGD
SCHEMBL418556 0.85 SERPINE1 (0.61) SERPINE1CNR1SMN1; SMN2ALDH1A1HPGD
SCHEMBL1015090 0.85 SERPINE1 (0.79) SERPINE1CNR1SMN1; SMN2ALDH1A1HPGD
SCHEMBL1015063 0.85 SERPINE1 (0.58) SERPINE1SMN1; SMN2THRBALDH1A1HPGD
SCHEMBL419000 0.84 SERPINE1 (0.60) SERPINE1CNR1SMN1; SMN2ALDH1A1HPGD
SCHEMBL1016186 0.81 THRB (0.54) SERPINE1CNR1SMN1; SMN2THRBALDH1A1
SCHEMBL419057 0.80 SERPINE1 (0.78) SERPINE1CNR1SMN1; SMN2ALDH1A1HPGD
SCHEMBL419148 0.78 SERPINE1 (0.82) SERPINE1SMN1; SMN2THRBALDH1A1NPC1
SCHEMBL1014985 0.78 SERPINE1 (1.00) SERPINE1CNR1KDM4EGAAADAMTS5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 SERPINE1 1/4885CNR1 3950/4885SMN1; SMN2 2290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.